| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5658 | Zofenoprilat | Inducer of functional angiogenesis through increased H 2 S availability |
|
| DCC5659 | Zolantidine Dimaleate | Potent, selective, and brain penetrating H2 receptor antagonist |
|
| DCC5660 | Zoledronate Disodium | Inhibitor of osteoclastogenesis and macrophage recruitment, decreasing bone turnover and stabilizing the bone matrix, exhibiting diverse anti-tumor effects in osteosarcoma |
|
| DCC5661 | Zolimidine | Gastroprotective agent for the treatment of peptic ulcer |
|
| DCC5662 | Zp1-12cl | Novel zinc sensor with a chloroalkane linker, reacting specifically with the engineered protein HaloTag, binding zinc ions with a threefold fluorescence enhancement |
|
| DCC5663 | Ztb23(r) | The first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor |
|
| DCC5664 | Ztz240 | Novel potentiator of KCNQ2 potassium channels |
|
| DCC5665 | Zu-4280011 | Novel COX-2 inhibitor |
|
| DCC5666 | Zuclopenthixol Dihydrochloride | Antagonist of D1 and D2 dopamine receptors. |
|
| DCC5667 | Z-wehd-fmk | Potent, cell-permeable and irreversible caspase-1/5 inhibitor |
|
| DCC5668 | Zwittermicin A | Natural antibiotic, having diverse biological activities including broad-spectrum antibiosis against Bacteria and lower Eukarya, plant disease suppression, and enhancement of the insecticidal activity of Bacillus thuringiensis toxin against lepidopteran l |
|
| DCC5669 | Zwm026 | Novel multi-target inhibitor, harboring selectivity of inhibiting EGFR T790M sparing wild-type EGFR |
|
| DCC5670 | Zxh-1-161 Featured | Novel Selective Degrader of GSPT1 |
|
| DCC5671 | Zx-j-19j | Novel inhibitor of Cyclophilin J (CyPJ) PPIase, demonstrating remarkable inhibition of tumor cell growth, comparable to CsA but much stronger than 5-fluorouracil |
|
| DCC5672 | Zx-j-19l | Novel inhibitor of Cyclophilin J (CyPJ) PPIase, demonstrating remarkable inhibition of tumor cell growth, comparable to CsA but much stronger than 5-fluorouracil |
|
| DCC5673 | Zxx2-77 | Cyclooxygenase-1 inhibitor |
|
| DCC5674 | Zydpla1 | Novel next generation orally active DPP-4 inhibitor to treat Type 2 Diabetes |
|
| DCC5675 | Zyj-25e | Novel histone deacetylase inhibitor (HDACi) with potent oral antitumor activities |
|
| DCC5676 | Zyj-34c | Novel histone deacetylase inhibitor (HDACi) with potent oral antitumor activities |
|
| DCC5677 | Zyj-34v | Oral active histone deacetylase inhibitor with potent antitumor activity |
|
| DCC5678 | Zyz-803 | Novel slow H2S-NO-releasing hybrid, attenuating cardiac dysfunction after heart failure |
|
| DC65802 | KT-621 | a STAT6 degrader for multiple immune-mediated diseases. |
|
| DC65821 | Upadacitinib hemihydrate Featured | Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor with an IC50 of 43 nM, being developed for the treatment of several autoimmune disorders. |
|
| DC65830 | 1-M-PES(1-Methoxy-5-methylphenazinium ethyl sulfate) Featured | 1-m-PES is an electron mediator which has higher stability of solutions than 1-Methoxy PMS. The stability in neutral to alkali conditions has been extremely improved with 1-Methoxy PES. 1-M-PES is a stable small-molecular compound and it has an equal or higher thermal stability than diaphorase. The 1-Methoxy PES solution can be stored long term. |
|
| DC65839 | MC1 Precursor Featured | Precursor of MC1, which is a selective and potent inhibitor for COX-2, used as the radioligands for development as clinically useful PET radioligands. |
|
| DC65841 | MC1 Featured | MC1 is a selective and potent inhibitor for COX-2, and [11C]MC1 detected COX-2 in nonhuman primates after intracerebral injection of an inflammogen. |
|
| DC60559 | PT-179 Featured | PT-179 is a new orthogonal immunomodulatory drug (IMiD) derivative that binds CRBN but does not induce degradation of off-target proteins. PT-179 potently degrades proteins fused to SD40 at either the N or C terminus. |
|
| DC72914 | UE2343 | UE2343 (UE-2343, Xanamem) is a potent, orally bioavailable, brain penetrant 11β-HSD1 inhibitor with IC50 of 24 nM in cell-free assays, with no activity for isozyme 11β-HSD2. |
|
| DC72915 | AM4085 | AM4085 is a potent, orally bioavailable lectin domain of FmLH antagonist with IC50 of 0.19 uM. |
|
| DC72916 | BB2-50F | BB2-50F is a bactericidal inhibitor of M. tuberculosis with MIC value of 8 uM (H37Rv), inhibits succinate dehydrogenase and the F1Fo-ATP synthase. |
|
